Tr1X Bio
2 known investors
Find your way into Tr1X Bio
Sign up to see every warm intro you have to Tr1X Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tr1X Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tr1X is a biopharmaceutical company developing cell and gene therapies to cure autoimmune and inflammatory diseases with high unmet medical need. The company translates scientific discoveries in immune regulation and regenerative medicine into novel patient therapies.
Founders & leadership
D
DavidCo-Founder
MG

Maria Grazia RoncaroloCo-Founder, President and Head of R&D
Investors · 2
Neva Sgr.listed by Neva Sgr.Turin
How we know: Neva Sgr.'s portfolio page · press coverage · the VCSheet dataset · Not right? Tell us
The Column Grouplisted by The Column GroupSan Francisco · $30M
How we know: The Column Group's portfolio page · press coverage · the VCSheet dataset · Not right? Tell us
In the news
Frequently asked questions
- What does Tr1X Bio do?
- Tr1X is a biopharmaceutical company developing cell and gene therapies to cure autoimmune and inflammatory diseases with high unmet medical need. The company translates scientific discoveries in immune regulation and regenerative medicine into novel patient therapies.
- Who founded Tr1X Bio?
- Tr1X Bio was founded by David, Maria Grazia Roncarolo.
- Who are Tr1X Bio's investors?
- Tr1X Bio's investors include Neva Sgr., The Column Group.

